Effects of a novel angiotensin AT 1 receptor antagonist, HR720, on rats with myocardial infarction

Author： Xia Q.-G.   Chung O.   Spitznagel H.   Sandmann S.   Illner S.   Rossius B.   Jahnichen G.   Reinecke A.   Gohlke P.   Unger T.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.385, Iss.2, 1999-12, pp. : 171-179

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valsartan: a novel angiotensin Type 1 receptor antagonist

By Thürmann P.A.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 337-350

Informa Healthcare

Access to resources Recommend Favorite

Effects of Angiotensin Receptor Blockade on Haemodynamics and Gene Expression after Myocardial Infarction

By Gurevich A.K.  

Drugs in R&D, Vol. 3, Iss. 4, 2002-01 ,pp. : 239-249

Adis International

Access to resources Recommend Favorite

Angiotensin receptor antagonist use does not appear to be associated with an increased risk of myocardial infarction

By  

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

By Shibasaki M.   Fujimori A.   Takanashi M.   Kusayama T.   Tokioka T.   Satoh Y.   Okazaki T.   Uchida W.   Inagaki O.   Yanagisawa I.  

European Journal of Pharmacology, Vol. 335, Iss. 2, 1997-09 ,pp. : 167-173

Elsevier

Access to resources Recommend Favorite

Angiotensin receptor blockers in acute myocardial infarction

By Salam Amar M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 427-430

Informa Healthcare

Access to resources Recommend Favorite